HealthTech Breakfast Club

by AlbionVC and Founders Factory

Archived event

Healthtech

In partership with

Hosted by

AlbionVC X Founders Factory bring a monthly breakfast club together to discuss emerging themes within the world of digital health.

The October edition of the HealthTech Breakfast Club was held at Creandum offices in London focusing on Digital Pharma – which parts of the clinical trial value chain are ripe for disruption?

Our panel to lead the discussion included:

• Meri Beckwith, Co-founder, Lindus Health
• Furat Shawki, Head of Clinical Trials, NuvoAir
• Dr. Myles Furnace, VP Commercial, Closed Loop Medicine
• Gemma Bloemen, Principal, Creandum

Key takeaways:

• About clinical trial value chain and the many organisations involved in different parts – Meri Beckwith made some great points about how Lindus Health are thinking about the workflow first rather than the organisations which enables great efficiency gains in the trials they run. Great to understand from Gemma Bloemen the Creandum thesis on digital pharma, why they are so excited about Lindus and where they are looking for new opportunities.
• Furat Shawki had some brilliant insights about how important patient retention is rather than just patient recruitment and the role technology can have in process simplification for both the patient and also the trial sites. Technology can also enable not just better patient adherence to PROMs (patient reported outcome measures) but also gather additional data in the background that can be useful.
• Dr. Myles Furnace on digital biomarkers and the complexity in their use as trial end points when many of them have not been validated individually/in combination for different indications and outcomes. Many of the end points that clinical trials optimise for are based on the ‘gold standard’ guideline from decades ago. Fascinating to understand the role the regulator can actually play in innovation too rather than a CRO which is often less financially incentivised to be efficient.

If you are founder building in the space, we’d love to hear from you. Reach out to @Molly Gilmartin or one of the AlbionVC team.